Cargando…

Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease()

OBJECTIVE: Respiratory viruses are a common trigger for exacerbations of chronic obstructive pulmonary disease (COPD). Human metapneumovirus (hMPV) is a paramyxovirus associated with respiratory tract infections and wheezing. Our aim was to determine whether hMPV was associated with exacerbations of...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinello, Richard A., Esper, Frank, Weibel, Carla, Ferguson, David, Landry, Marie L., Kahn, Jeffrey S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Society. Published by Elsevier Ltd. 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112509/
https://www.ncbi.nlm.nih.gov/pubmed/16412516
http://dx.doi.org/10.1016/j.jinf.2005.11.010
_version_ 1783513488208953344
author Martinello, Richard A.
Esper, Frank
Weibel, Carla
Ferguson, David
Landry, Marie L.
Kahn, Jeffrey S.
author_facet Martinello, Richard A.
Esper, Frank
Weibel, Carla
Ferguson, David
Landry, Marie L.
Kahn, Jeffrey S.
author_sort Martinello, Richard A.
collection PubMed
description OBJECTIVE: Respiratory viruses are a common trigger for exacerbations of chronic obstructive pulmonary disease (COPD). Human metapneumovirus (hMPV) is a paramyxovirus associated with respiratory tract infections and wheezing. Our aim was to determine whether hMPV was associated with exacerbations of COPD. METHODS: The study was designed as an observational cohort study carried out in a 944-bed urban teaching hospital located in New Haven, Connecticut. Between December 2002 and May 2003, patients hospitalized due to an exacerbation of COPD were identified. Nasopharyngeal specimens obtained from these patients were tested for human metapneumovirus by RT–PCR and for respiratory syncytial virus, influenza A and B, parainfluenza-1, -2, and -3 and adenovirus by a cytospin-enhanced direct immunofluorescence assay and/or viral culture. RESULTS: Fifty individuals met enrollment criteria and hMPV was identified in 6 (12%), respiratory syncytial virus in 4 (8%), influenza A in 2 (4%) and parainfluenza type 3 in 1 (2%) patients. Both A and B hMPV genotypes were identified in patients hospitalized due to exacerbations of COPD. CONCLUSION: hMPV was frequently identified in patients hospitalized due to an exacerbation of COPD. Further studies are necessary to determine the epidemiology and the impact of hMPV in COPD patients.
format Online
Article
Text
id pubmed-7112509
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher The British Infection Society. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71125092020-04-02 Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease() Martinello, Richard A. Esper, Frank Weibel, Carla Ferguson, David Landry, Marie L. Kahn, Jeffrey S. J Infect Article OBJECTIVE: Respiratory viruses are a common trigger for exacerbations of chronic obstructive pulmonary disease (COPD). Human metapneumovirus (hMPV) is a paramyxovirus associated with respiratory tract infections and wheezing. Our aim was to determine whether hMPV was associated with exacerbations of COPD. METHODS: The study was designed as an observational cohort study carried out in a 944-bed urban teaching hospital located in New Haven, Connecticut. Between December 2002 and May 2003, patients hospitalized due to an exacerbation of COPD were identified. Nasopharyngeal specimens obtained from these patients were tested for human metapneumovirus by RT–PCR and for respiratory syncytial virus, influenza A and B, parainfluenza-1, -2, and -3 and adenovirus by a cytospin-enhanced direct immunofluorescence assay and/or viral culture. RESULTS: Fifty individuals met enrollment criteria and hMPV was identified in 6 (12%), respiratory syncytial virus in 4 (8%), influenza A in 2 (4%) and parainfluenza type 3 in 1 (2%) patients. Both A and B hMPV genotypes were identified in patients hospitalized due to exacerbations of COPD. CONCLUSION: hMPV was frequently identified in patients hospitalized due to an exacerbation of COPD. Further studies are necessary to determine the epidemiology and the impact of hMPV in COPD patients. The British Infection Society. Published by Elsevier Ltd. 2006-10 2006-01-10 /pmc/articles/PMC7112509/ /pubmed/16412516 http://dx.doi.org/10.1016/j.jinf.2005.11.010 Text en Copyright © 2005 The British Infection Society. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Martinello, Richard A.
Esper, Frank
Weibel, Carla
Ferguson, David
Landry, Marie L.
Kahn, Jeffrey S.
Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease()
title Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease()
title_full Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease()
title_fullStr Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease()
title_full_unstemmed Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease()
title_short Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease()
title_sort human metapneumovirus and exacerbations of chronic obstructive pulmonary disease()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112509/
https://www.ncbi.nlm.nih.gov/pubmed/16412516
http://dx.doi.org/10.1016/j.jinf.2005.11.010
work_keys_str_mv AT martinelloricharda humanmetapneumovirusandexacerbationsofchronicobstructivepulmonarydisease
AT esperfrank humanmetapneumovirusandexacerbationsofchronicobstructivepulmonarydisease
AT weibelcarla humanmetapneumovirusandexacerbationsofchronicobstructivepulmonarydisease
AT fergusondavid humanmetapneumovirusandexacerbationsofchronicobstructivepulmonarydisease
AT landrymariel humanmetapneumovirusandexacerbationsofchronicobstructivepulmonarydisease
AT kahnjeffreys humanmetapneumovirusandexacerbationsofchronicobstructivepulmonarydisease